bioRxivGenomicsPreprint
Characterizing and comparing missense variants in monogenic disease and in cancer
Abstract
In both monogenic disease and cancer a large fraction of causative mutations are missense, even though these are very different types of disease. Here we examine and compare a number of properties of these mutations in the two classes of disease to determine the extent to which the properties of the mutations are similar or different. Analysis of cancer mutations is complicated by the problem of distinguishing between drivers and passengers. After controlling for this factor in three different ways, we find the following: (1) A very high and similar fraction (~90%) of causal mutations in both diseases are at positions under strong selection pressure. (2) Mutations in structurally disordered regions play a minor role in monogenic disease (only about 10% of mutations are in those regions), but a larger role (about 25%) in cancer, largely because of the higher fraction of disordered regions in cancer driver proteins. (3) A large (~75%) and similar fraction of causal mutations in protein cores in both diseases act by significantly destabilizing three-dimensional structure, implying a large impact on protein function. (4) Cancer oncogene mutations tend to be on the protein surface whereas tumor suppressor and monogenic disease mutations are more common in the core. (5) A surprisingly high fraction (~50%) of mutations in cancer passenger genes are at positions under strong selection pressure.
- assay: DNA methylation
- assay: whole-exome sequencing
- research focus: variant effect prediction
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: variant calling
- approach: statistical model
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Protein structural context of cancer mutations reveals molecular mechanisms and identifies novel candidate driver genes
Diego Chillón Pino, Mihaly Badonyi, … Joseph A. Marsh·bioRxiv·Mar 21, 2024
- The effects of mutational process and selection on driver mutations across cancer types
D. Temko, I. Tomlinson, … T. Graham·bioRxiv·Jun 12, 2017
- Cancer-driving mutations are enriched in genic regions intolerant to germline variation
Dimitrios Vitsios, Ryan S. Dhindsa, … Slavé Petrovski·Science AdvancesPeer-reviewed·Aug 26, 2022
- An interpretable molecular framework for predicting cancer driver missense mutations
Yan Yang, Weikang Sun, … Minghui Li·Proceedings of the National Academy of SciencesPeer-reviewed·Feb 3, 2026
- Mutation bias in driver genes reveals the distribution of effects of oncogenic mutations
Anastasia V. Stolyarova, Georgii A. Bazykin·bioRxiv·Sep 25, 2025
- Motif Disruption Domains Lead To Cancer Gene Expression Rewiring
Fabien C. Lamaze, Aurelien Chateigner, … Philip Awadalla·bioRxiv·Apr 11, 2017